Mitotane's Primary Indication: Adrenocortical Carcinoma
Mitotane (Lysodren) holds a central role in the systemic treatment of adrenocortical carcinoma (ACC), a rare and aggressive cancer of the adrenal glands. It is the only drug specifically approved for this condition. Its use is indicated in various stages of ACC, particularly when the disease is advanced, unresectable, or has metastasized. Mitotane's cytotoxic effect targets the adrenal cortex, including both cancerous and some healthy cells.
Adjuvant Therapy for High-Risk Patients
Mitotane is also used as an adjuvant therapy following surgery for patients with ACC who are at high risk of recurrence. While this specific use is often considered off-label, it is recommended by several treatment guidelines, including those endorsed by the European Society of Endocrinology (ESE) and the European Network for the Study of Adrenal Tumours (ENSAT). The goal of adjuvant therapy is to eliminate any microscopic cancer cells that might remain after surgery, potentially delaying or preventing disease relapse. For optimal effectiveness, therapeutic plasma concentrations of mitotane must be reached and maintained, which can be a slow process.
Mitotane's Off-Label Use in Cushing's Syndrome
In addition to its role in adrenal cancer, mitotane is sometimes used off-label to treat Cushing's syndrome, a condition caused by the body producing too much cortisol. Mitotane's ability to inhibit steroid synthesis and destroy adrenal tissue helps control the excessive hormone production in these patients.
- Controlling Hypercortisolism: Mitotane can be effective in normalizing cortisol levels in a significant portion of Cushing's syndrome patients.
- Used for Resistant Cases: Due to its potential for serious side effects and the availability of better-tolerated alternatives, mitotane is typically reserved for patients who have not responded adequately to other treatments.
- Slow Onset of Action: The time it takes for mitotane to effectively control cortisol levels can be several months, meaning it is not suitable for situations requiring immediate hormonal control.
How Mitotane Works: Mechanism of Action
Mitotane exerts its effects through a dual mechanism that targets the adrenal cortex. This includes a direct adrenocorticolytic effect and the inhibition of specific enzymes involved in steroid hormone production.
- Adrenocorticolytic Activity: Mitotane directly damages and kills cells in the adrenal cortex, a process known as adrenolysis. It primarily affects the zona fasciculata and zona reticularis, which are responsible for producing cortisol and an... (text truncated due to character limit)